Cargando…

Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action

BACKGROUND: Critically ill COVID-19 patients have a clear pattern of inflammation and hypercoagulable state. The main aim of the study was to evaluate the outcome of severe COVID-19 patients basing on prothrombotic risk factors (i.e. D-dimer). We also evaluated the impact of different doses of low m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavoni, Vittorio, Gianesello, Lara, Pazzi, Maddalena, Stera, Caterina, Meconi, Tommaso, Frigieri, Francesca Covani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487146/ https://www.ncbi.nlm.nih.gov/pubmed/32977129 http://dx.doi.org/10.1016/j.thromres.2020.09.013

Ejemplares similares

Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Risk factors for non-invasive/invasive ventilatory support in patients with COVID-19 pneumonia: A retrospective study within a multidisciplinary approach
por: Suardi, Lorenzo Roberto, et al.
Publicado: (2020)

Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests
por: Pavoni, Vittorio, et al.
Publicado: (2021)

Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?
por: Pavoni, Vittorio, et al.
Publicado: (2021)

Aspirin/enoxaparin sodium/heparin: Bleeding: 3 case reports
Publicado: (2021)

Addition of aspirin to venous thromboembolism chemoprophylaxis safely decreases venous thromboembolism rates in trauma patients
por: Lammers, Daniel, et al.
Publicado: (2023)

Safety of heparin prophylaxis for venous thromboembolism in patients with neurotrauma
por: Puri, G, et al.
Publicado: (2010)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin
por: Boonyawat, Kochawan, et al.
Publicado: (2021)

Venous thromboembolism in patients hospitalised with COVID-19 in England
por: Roberts, Lara N., et al.
Publicado: (2022)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Antiphospholipid antibodies and thrombosis in severe COVID-19 pneumonia: A difficult relationship
por: Pavoni, Vittorio, et al.
Publicado: (2020)

COVID-19 infection: Is the outcome time-dependent?
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
por: Smythe, Maureen A., et al.
Publicado: (2016)

Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial
por: Haac, Bryce E., et al.
Publicado: (2020)

Risk‐Stratified Venous Thromboembolism Prophylaxis after Total Joint Arthroplasty: Low Molecular Weight Heparins and Sequential Aspirin vs Aggressive Chemoprophylaxis
por: Peng, Hui‐ming, et al.
Publicado: (2021)

Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis
por: Porfidia, Angelo, et al.
Publicado: (2020)

Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients
por: Dujardin, Romein W.G., et al.
Publicado: (2020)

Bleeding risk assessment for venous thromboembolism prophylaxis
por: Chindamo, Maria Chiara, et al.
Publicado: (2021)

Evidence-base for aspirin as venous thromboembolic prophylaxis following joint replacement
por: Jameson, S. S., et al.
Publicado: (2014)

Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk
por: Muster, Viktoria, et al.
Publicado: (2021)

Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia
por: Hisada, Yohei, et al.
Publicado: (2023)

The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy
por: Zou, Peimei, et al.
Publicado: (2019)

Inpatient compliance with venous thromboembolism prophylaxis after orthopaedic trauma: results from a randomized controlled trial of aspirin versus low molecular weight heparin
por: Haac, Bryce E., et al.
Publicado: (2021)

The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials
por: Meng, Jiahao, et al.
Publicado: (2023)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
por: Spyropoulos, Alex C, et al.
Publicado: (2008)

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
por: Lodigiani, Corrado, et al.
Publicado: (2020)

Spontaneous Heparin-Induced Thrombocytopenia and Venous Thromboembolism following Total Knee Arthroplasty
por: Baker, Kevin, et al.
Publicado: (2017)

Combined pericapsular nerve group and lateral femoral cutaneous nerve blocks for hip fracture in a polytraumatized patient—A case report
por: Valoriani, Juri, et al.
Publicado: (2022)

Unfractionated heparin or low-molecular-weight heparin for venous thromboembolism prophylaxis after hepatic resection: A meta-analysis
por: Zhang, Wentao, et al.
Publicado: (2022)

Risk assessment of venous thromboembolism and bleeding in COVID‐19 patients
por: Wang, Lan, et al.
Publicado: (2022)

Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolism
por: Wilson, Nathaniel R., et al.
Publicado: (2020)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
por: Klok, Frederikus A., et al.
Publicado: (2019)

Retrospective Cohort Analysis of Aspirin Use and Venous Thromboembolism in Patients with Pancreatic Cancer and an Indwelling Central Venous Catheter
por: King, Richard, et al.
Publicado: (2022)

Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions
por: Azboy, I., et al.
Publicado: (2017)

Pulmonary Embolism While on Aspirin for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty
por: Roman, Francisco, et al.
Publicado: (2018)

Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban()
por: Colleoni, Jose Luiz, et al.
Publicado: (2017)

Aspirin used for venous thromboembolism prophylaxis in total hip arthroplasty decreases heterotopic ossification
por: Vaz, Kenneth M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5d7nmi55p17rne5mc1tbit6bie